Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Prescribing

GP-based audit intervention helps cut high-risk prescribing

High-risk prescribing fell by 2.2% in participants of the GP surgery-based audit, but results were only short-term, showing that the intervention needs to be used regularly.

Results from a pharmacist-delivered audit pilot show that it reduced levels of high-risk prescribing in general practice, study results have shown[1].

The study, published in the British Journal of General Practice Open (online, 10 July 2018), trialled the Safer Prescribing and Care for the Elderly (SPACE) intervention, an automated audit system designed to foster patient engagement in medicines management and prompt medicines review.

The pilot audit was conducted at two GP surgeries in New Zealand with a total of 10,444 patients at increased risk of an adverse drug reaction from non-steroidal anti-inflammatory drugs and/or antiplatelet medicines. A pharmacist then went through the list of at-risk patients with each GP before patients were encouraged, by post, to discuss their medicines with their GP.

At six months, there was a significant reduction in the proportion of study participants receiving high-risk prescribing, from 8.0% to 5.8%, compared with baseline. However, this was not maintained at 12 months, when high-risk prescribing returned to baseline levels.

The team said the results showed the feasibility of incorporating the SPACE intervention into existing practice, but it may need to be used regularly to sustain its effects.

“The aim is to reduce the incidence of related [adverse drug reactions] … particularly among older adults who make up the majority of vulnerable patients,” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205386

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.